Rate of emergency department (ED) care for asthma has long been used as a benchmark metric of asthma morbidity within a population. National data on asthma ED use and hospitalizations collected in the 1980s and 1990s provided alarming evidence of increasing rates of asthma morbidity across broad sections of the population, with disproportionately high rates for minority adults and children with asthma. 1 On the basis of this evidence that asthma morbidity was a significant and growing public health problem, the National Institutes of Health, professional organizations, and multiple health care organizations launched extensive national educational and health care quality initiatives to educate physicians and other health care workers about asthma. The goal of all these diverse initiatives has ultimately been to reduce overall asthma morbidity and help all patients with asthma achieve better asthma control.
In the current issue, Ginde et al 2 provide evidence that progress may have been made in reducing acute asthma morbidity for some but not all populations. By using data from the National Hospital and Ambulatory Medical Care Survey, they describe trends in asthma-related ED use from 1993 through 2005 and report that although asthma-related ED use increased throughout the late 1990s, more recent data suggest that overall rates have plateaued. From a peak rate of 7.6 asthma-related ED visits per 1000 persons in 1998, the rate by 2005 decreased to 6.0. The authors suggest that the observed stabilization is likely attributable to successful national efforts to improve asthma management, particularly the increased use of long-term controller medications. 3 However, although these data provide some encouraging news that rates of asthma morbidity are not continuing to skyrocket, the sobering reality is that current asthma-related ED use still remains unnecessarily high. As the authors note, the great majority of ED visits for asthma can be prevented by effective asthma management by clinicians and patients. The data reported by Ginde et al 2 highlight the potential to effect positive change in controlling asthma through professional education, while underscoring the need for additional improvement.
More troubling is the differential improvement observed for rates of asthma-related ED use in white and black populations. For white patients, the rate of asthma-related ED use has decreased by 25% from 1998 to 2005; however, since 2000, the rate for black patients has trended upward. In fact, Ginde et al for black adults and children compared with white subjects (21.0 per 100 for black subjects with current asthma vs 7.0 for white subjects with current asthma), confirming that these disparities are not attributable to differing rates of asthma prevalence. 1 Further, the Centers for Disease Control and Prevention also reported that Hispanic subjects had higher rates of at-risk-based ED visits than non-Hispanic subjects (12.4 per 100 for Hispanic subjects with current asthma versus 8.4 for non-Hispanic subjects with current asthma). Others have reported that asthma disparities continue to be particularly high for Puerto Rican children and adults. 4, 5 Taken together, these data suggest that the disparity gap may have actually increased during the same time frame in which multiple, broad-based public and private health initiatives were implemented to reduce asthma morbidity, including widespread dissemination of the National Asthma Education and Prevention Program guidelines, as well as associated education programs for medical professionals, schools, and patients; the adoption of asthma quality-of-care measures by 90% of America's health care plans; and special initiatives by many health care agencies and plans specifically targeting asthma-related health disparities. 3, [6] [7] [8] [9] The question is therefore why increased public health efforts to improve asthma control across all people apparently benefited only some people. Were these diverse asthma education and quality-of-care initiatives insufficient, misdirected, or simply ineffectual in addressing asthma-related health disparities? Some researchers have suggested that none of the above apply, and that in fact, efforts to improve the health of the overall population will invariability increase the gap in health between majority and disadvantaged populations, because those with more education and resources will be most able to adopt and benefit from health care innovations and initiatives. 10, 11 However, others have argued that there is no predictable pattern of increasing or decreasing health disparities when overall population health improves, and that improvements in population health are dependent on social and political priorities, as well as the effectiveness of specific health policies and programs. 12 Krieger et al 12 hypothesize that social factors that influence levels of health inequity include ''rising levels of medical uninsurance, persistent racial/ ethnic and socioeconomic disparities in the quality of medical care, and delayed access of underserved populations to effective medical innovations.'' Based on this perspective, effective strategies to reduce asthma-related disparities would require going beyond inhaled corticosteroid (ICS) prescribing, to addressing more directly the relevant systemic, social, and behavioral determinants of asthma health.
Recently, multiple authors in this Journal have contributed thoughtful analyses of the contributing roles of genetic, environmental, community, and cultural factors to asthma disparities. 4, [13] [14] [15] [16] [17] The Institute of Medicine report on health inequities has also described systemic health care factors, including bias, stereotyping, and clinical uncertainty, that contribute to these disparities. 18 Consistent with the Institute of Medicine report, multiple studies have confirmed that disparities in health care exist for asthma, with minority patients less likely to receive guideline-based treatment from their providers. For example, Okelo et al 19 found that physicians tended to underestimate asthma severity in black patients compared with white patients. The investigators suggested that underestimation of asthma severity may contribute to undermanagement of asthma in minority patients. Supporting this observation, several studies have found that minority adults and children are less likely to receive inhaled corticosteroid controller therapy and other components of guideline-based care, such as asthma action plans, allergen counseling, or referral to a specialist. [20] [21] [22] In addition to deficits in asthma medical management, a number of studies suggest that minority patients may be more likely to share health beliefs about asthma and asthma management that are not congruent with effective asthma management. [23] [24] [25] Halm et al 26 surveyed low-income, inner-city patients hospitalized for asthma and examined beliefs about asthma care and chronicity. They found that the majority of patients believed they had asthma only when they were symptomatic (''no symptoms, no asthma''), and this belief was in turn associated with lower ICS adherence. Similarly, Le et al 27 found that black adults with asthma were less likely to use their ICS inhaler than white patients, and this adherence difference was mediated by more negative beliefs about the needs for ICS therapy among black patients. When patients believe that asthma comes and goes, it is understandable that they would be less likely to use controller therapies regularly, which in turn can contribute to poorer asthma control. In addition, patients whose asthma self-care is driven primarily by the urgency of symptoms may be more likely to delay treatment too long and thus require ED care.
There is growing evidence that patient-provider asthma communication during the clinical encounter may be a critical and promising juncture for addressing health disparities and translating guidelines into improved asthma management. Effective, patient-centered communication can result in more accurate clinical assessment of asthma, identification of health literacy barriers to understanding and self-care, increased patient trust and acceptance of therapy, and improved adherence. 28 Although routine outpatient care rightly remains the appropriate setting for regular asthma management and communication, a number of researchers have argued that the time has come to incorporate more elements of chronic asthma education, communication, and treatment into the ED encounter. 29 Reversing the increasing gap in asthma-related ED use will require innovative, national efforts to translate, tailor, and adapt asthma guidelines further for diverse populations with differential risk. Recent guideline revisions that now explicitly assess and address patient risk, including history of ED use, is a positive step in this direction. 30 More broadly, public policy needs to acknowledge and address how economic, social, and environmental factors directly and indirectly contribute to asthma health disparities. Together, these efforts have the potential to extend the reductions in ED morbidity described by Ginde et al 2 to all patients, regardless of race, age, or sex.
